OBJECTIVE: For people living with HIV, treatment adherence self-efficacy is an important predictor of treatment adherence and, therefore, of clinical outcomes. Using experience sampling method (ESM), this study aimed to examine: (1) the within-person association between moment-to-moment changes in social support and HIV treatment self-efficacy; (2) the moderators of this within-person association; (3) the concordance between questionnaire and ESM measurement of treatment self-efficacy; and (4) the utility of each approach (ESM and questionnaire) in predicting adherence to medication, adherence to clinic visits, CD4 counts, and viral load. METHOD: Men living with HIV (N = 109) responded to the same set of ESM questions 3 times a day for 7 days via a smart phone given to them for the study. They also completed cross-sectional questionnaires and their clinic data was extracted from medical records to examine predictors and consequences of state and trait treatment self-efficacy. RESULTS: In within-person hierarchical linear modeling (HLM) analyses, receipt of recent social support predicted higher current ESM treatment self-efficacy. This association was stronger for individuals reporting higher avoidance coping with HIV. The correlation between ESM and questionnaire measures of treatment self-efficacy was r = .37. ESM measure of average treatment self-efficacy predicted medication adherence, visit adherence, CD4 counts, and viral load, while questionnaire-based self-efficacy did not predict these outcomes. CONCLUSION: Interventions aimed at improving treatment adherence may target social support processes, which may improve treatment self-efficacy and adherence. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
OBJECTIVE: For people living with HIV, treatment adherence self-efficacy is an important predictor of treatment adherence and, therefore, of clinical outcomes. Using experience sampling method (ESM), this study aimed to examine: (1) the within-person association between moment-to-moment changes in social support and HIV treatment self-efficacy; (2) the moderators of this within-person association; (3) the concordance between questionnaire and ESM measurement of treatment self-efficacy; and (4) the utility of each approach (ESM and questionnaire) in predicting adherence to medication, adherence to clinic visits, CD4 counts, and viral load. METHOD:Men living with HIV (N = 109) responded to the same set of ESM questions 3 times a day for 7 days via a smart phone given to them for the study. They also completed cross-sectional questionnaires and their clinic data was extracted from medical records to examine predictors and consequences of state and trait treatment self-efficacy. RESULTS: In within-person hierarchical linear modeling (HLM) analyses, receipt of recent social support predicted higher current ESM treatment self-efficacy. This association was stronger for individuals reporting higher avoidance coping with HIV. The correlation between ESM and questionnaire measures of treatment self-efficacy was r = .37. ESM measure of average treatment self-efficacy predicted medication adherence, visit adherence, CD4 counts, and viral load, while questionnaire-based self-efficacy did not predict these outcomes. CONCLUSION: Interventions aimed at improving treatment adherence may target social support processes, which may improve treatment self-efficacy and adherence. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
Authors: Mallory O Johnson; Torsten B Neilands; Samantha E Dilworth; Stephen F Morin; Robert H Remien; Margaret A Chesney Journal: J Behav Med Date: 2007-06-23
Authors: Meirav Dagan; Robbert Sanderman; Marike C Schokker; Theo Wiggers; Peter C Baas; Michiel van Haastert; Mariët Hagedoorn Journal: J Fam Psychol Date: 2011-04
Authors: Ben S Gerber; Maria Pagcatipunan; Everett V Smith; Semonti S Basu; Kimberly A Lawless; Louanne I Smolin; Michael L Berbaum; Irwin G Brodsky; Arnold R Eiser Journal: J Appl Meas Date: 2006
Authors: David R Bangsberg; Edward P Acosta; Reena Gupta; David Guzman; Elise D Riley; P Richard Harrigan; Neil Parkin; Steven G Deeks Journal: AIDS Date: 2006-01-09 Impact factor: 4.177
Authors: Whitney S Rice; Bulent Turan; Faith E Fletcher; Tessa M Nápoles; Melonie Walcott; Abigail Batchelder; Mirjam-Colette Kempf; Deborah J Konkle-Parker; Tracey E Wilson; Phyllis C Tien; Gina M Wingood; Torsten B Neilands; Mallory O Johnson; Sheri D Weiser; Janet M Turan Journal: AIDS Patient Care STDS Date: 2019-04 Impact factor: 5.078
Authors: Victoria C Seghatol-Eslami; Heather E Dark; James L Raper; Michael J Mugavero; Janet M Turan; Bulent Turan Journal: J Acquir Immune Defic Syndr Date: 2017-01-01 Impact factor: 3.731
Authors: Bulent Turan; Henna Budhwani; Pariya L Fazeli; Wesley R Browning; James L Raper; Michael J Mugavero; Janet M Turan Journal: AIDS Behav Date: 2017-01
Authors: Akilah J Dulin; Sannisha K Dale; Valerie A Earnshaw; Joseph L Fava; Michael J Mugavero; Sonia Napravnik; Joseph W Hogan; Michael P Carey; Chanelle J Howe Journal: AIDS Care Date: 2019-01-11
Authors: C Blake Helms; Janet M Turan; Ghislaine Atkins; Mirjam-Colette Kempf; Olivio J Clay; James L Raper; Michael J Mugavero; Bulent Turan Journal: AIDS Behav Date: 2017-01